Nephrocalcinosis: Clinical Trials

2 trials for Nephrocalcinosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Nephrocalcinosis: new trials by email Literature Review of Nephrocalcinosis trials Research Report on Nephrocalcinosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis
Phase 2 / Phase 3UnknownAlbany Medical College102015-02-012015-01-26
Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature
Potassium Citrate, Placebo - Nephrocalcinosis
Phase 3UnknownJuan A. Arnaiz742013-01-012012-12-27

Narrower conditions

Glomerulonephritis (1)  ·  Hypercalcemia (1)  ·  Hypercalciuria (1)  ·  Nephritis, Interstitial (1)  ·  Nephrolithiasis (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sarcoidosis (1)

Broader conditions

Calcinosis (2)  ·  Calcium Metabolism Disorders (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)

Interventions

Adrenocorticotropic Hormone (1)  ·  Potassium Citrate (1)

Sponsors

Albany Medical College (1)  ·  Juan A. Arnaiz (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Francisco Botet Mussons, MD (1)  ·  Marc A Judson, MD (1)